Olink Holding AB (publ) (NASDAQ:OLK) Releases Earnings Results, Beats Expectations By $0.07 EPS

Olink Holding AB (publ) (NASDAQ:OLK) announced its earnings results on Wednesday. The company reported ($0.01) EPS for the quarter, beating analysts’ consensus estimates of ($0.08) by $0.07, Briefing.com reports. Olink Holding AB (publ) had a negative return on equity of 4.05% and a negative net margin of 11.72%. The firm had revenue of $44.15 million for the quarter, compared to analysts’ expectations of $42.62 million.

Olink Holding AB (publ) Trading Up 0.1 %

OLK traded up $0.02 during trading on Friday, reaching $25.85. 559,774 shares of the company’s stock were exchanged, compared to its average volume of 515,771. The company has a current ratio of 7.41, a quick ratio of 5.84 and a debt-to-equity ratio of 0.01. Olink Holding AB has a one year low of $14.10 and a one year high of $26.47. The firm has a fifty day moving average price of $19.52 and a two-hundred day moving average price of $18.95. The stock has a market capitalization of $3.21 billion, a PE ratio of -184.49 and a beta of 0.60.

Wall Street Analysts Forecast Growth

A number of research firms recently commented on OLK. Leerink Partnrs downgraded Olink Holding AB (publ) from an “outperform” rating to a “market perform” rating in a research note on Tuesday, October 17th. Scotiabank reiterated a “sector perform” rating on shares of Olink Holding AB (publ) in a research report on Wednesday, October 18th. Finally, Morgan Stanley upped their price objective on shares of Olink Holding AB (publ) from $18.00 to $26.00 and gave the stock an “equal weight” rating in a report on Tuesday, October 24th. Four research analysts have rated the stock with a hold rating and one has assigned a buy rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $24.75.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of OLK. Price T Rowe Associates Inc. MD lifted its holdings in shares of Olink Holding AB (publ) by 25.1% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 9,499,355 shares of the company’s stock worth $214,021,000 after acquiring an additional 1,905,330 shares during the last quarter. FMR LLC grew its position in shares of Olink Holding AB (publ) by 4.2% in the 1st quarter. FMR LLC now owns 12,410,837 shares of the company’s stock worth $279,616,000 after buying an additional 501,026 shares during the period. Gilder Gagnon Howe & Co. LLC boosted its stake in Olink Holding AB (publ) by 480.0% in the 1st quarter. Gilder Gagnon Howe & Co. LLC now owns 439,453 shares of the company’s stock worth $9,901,000 after purchasing an additional 363,680 shares in the last quarter. Envestnet Asset Management Inc. boosted its stake in Olink Holding AB (publ) by 2,904.8% in the 1st quarter. Envestnet Asset Management Inc. now owns 358,324 shares of the company’s stock worth $182,000 after purchasing an additional 346,399 shares in the last quarter. Finally, Principal Financial Group Inc. boosted its stake in Olink Holding AB (publ) by 38.4% in the 1st quarter. Principal Financial Group Inc. now owns 940,888 shares of the company’s stock worth $21,198,000 after purchasing an additional 260,913 shares in the last quarter. Institutional investors and hedge funds own 32.25% of the company’s stock.

About Olink Holding AB (publ)

Olink Holding AB (publ) provides various products and services for the academic, government, biopharmaceutical, biotechnology, service provider, and other institutions that focuses on life science research. The company's products include Olink Explore for cardiovascular and metabolic, oncology, neurology, or inflammation diseases; Olink Target product line; Olink Flex, a low-plex applications and use-cases; and Olink Focus product line that consists of custom developed solutions for customers that has identified various proteins of interest or a protein signature to focus on.